A retrospective study on implementing EBP guideline to improve provider assessment of metabolic complication among patients on antipsychotic medication
Descriptive Metadata
Rights Metadata
Technical Metadata
Descriptive
TitleInfo
Title
A retrospective study on implementing EBP guideline to improve provider assessment of metabolic complication among patients on antipsychotic medication
LanguageTerm (authority = ISO 639-3:2007); (type = text)
English
Abstract (type = abstract)
Unmonitored and continued use of antipsychotic medication by psychiatric patients has been linked to an increase of various metabolic complications in this population (Kioko et al., 2016; Lee et al., 2016). While antipsychotic medications are useful in the management of the psychiatric disorders, their deleterious side effects can lead to adverse medical conditions such as cardiovascular diseases as well as Type II diabetes. Overall, apart from the impact of the psychiatric disorders, the occurrence of these other physical illnesses can diminish the life expectancy as well as raise Healthcare costs associated with such individuals. Screening and early diagnosis of these metabolic complications can improve the clinical outcomes for these patients (Ruiz et al., 2016). Therefore, the implementation of guidelines useful in monitoring possible metabolic complications can be useful in minimizing such repercussions. The objective of this paper is to outline the recommended EBP guidelines for monitoring the safety and effectiveness of antipsychotic medications in psychiatric patients to reduce the level of occurrence of the common metabolic syndromes associated with these medications. A retrospective study based on chart review of past medical records of patients with metabolic complications associated with the use of antipsychotic medications in the Inpatient Psychiatric Hospital was employed in this study to outline some of the significant evidence-based guidelines on the management and monitoring of patients on antipsychotic medications. This study presented evidence-based recommendations for the management and monitoring of occurrence of metabolic complications in patients on antipsychotic medications to reduce the occurrence of metabolic complications.
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.